Histone acetylation modulators in breast cancer

Area of Science:

• Oncology
• Epigenetics
• Immunology

Background:

• Breast cancer is a leading global cancer in women.
• Epigenetic alterations, specifically histone acetylation dysregulation, are implicated in breast cancer development.
• Histone acetylation modulators are emerging as potential therapeutic agents.

Purpose of the Study:

• To comprehensively review the roles of histone acetylation modulators in breast cancer.
• To examine the effects of histone acetylation inhibitors on breast cancer.
• To highlight the impact of epigenetic reprogramming on immunosuppressive myeloid cells in breast cancer progression.

Main Methods:

• Literature review of epigenetic reprogramming in breast cancer.
• Analysis of histone acetylation modulators and their inhibitors.
• Investigation of the interplay between histone acetylation and immunosuppressive myeloid cells.

Main Results:

• Histone acetylation modulators influence both breast cancer cells and immunosuppressive myeloid cells.
• Dysregulated histone acetylation contributes to breast cancer progression.
• Modulators can alter the function and phenotype of immunosuppressive myeloid cells.

Conclusions:

• Histone acetylation modulators represent promising therapeutic targets for breast cancer.
• Targeting epigenetic mechanisms offers a novel strategy for breast cancer treatment.
• Understanding the role of myeloid cells in conjunction with epigenetic modulators is crucial for effective therapy.